Cargando…
Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients
SIMPLE SUMMARY: Treating the PDAC (pancreatic ductal adenocarcinoma) zPDXs (zebrafish patient-derived xenografts) with chemotherapy regimens commonly used, we performed a co-clinical trial testing the predictiveness of the model. We found that zPDX may predict patient outcomes, classifying them into...
Autores principales: | Usai, Alice, Di Franco, Gregorio, Piccardi, Margherita, Cateni, Perla, Pollina, Luca Emanuele, Vivaldi, Caterina, Vasile, Enrico, Funel, Niccola, Palmeri, Matteo, Dente, Luciana, Falcone, Alfredo, Giunchi, Dimitri, Massolo, Alessandro, Raffa, Vittoria, Morelli, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394309/ https://www.ncbi.nlm.nih.gov/pubmed/34439284 http://dx.doi.org/10.3390/cancers13164131 |
Ejemplares similares
-
Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients
por: Di Franco, Gregorio, et al.
Publicado: (2022) -
A Model of a Zebrafish Avatar for Co-Clinical Trials
por: Usai, Alice, et al.
Publicado: (2020) -
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine
por: Di Franco, Gregorio, et al.
Publicado: (2020) -
Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology
por: Palmeri, Matteo, et al.
Publicado: (2020) -
Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma
por: Bianchini, Matteo, et al.
Publicado: (2021)